¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ

¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ scientists have identified a drug that can be repurposed to prevent COVID-19 in research involving a unique mix of ‘mini-organs’, donor organs, animal studies and patients.

¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus, an approach that could be used to develop a new generation of antiviral drugs.

¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ is among 12 institutions across the UK that will be working together to tackle the monkeypox outbreak, developing better diagnostic tests, identifying potential therapies and studying vaccine effectiveness and the virus’ spread.

Referrals to ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ’s long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the successful rollout of the vaccine.

Scientists say continuous monitoring of the cholera bug genome is key to preventing outbreaks of new variants.

Scientists have released the first real-world data from Africa on the effectiveness of two doses of AstraZeneca/ChaAd0x-1 COVID-19 vaccination, showing that while protective against SARS-CoV-2, immunity against the Delta and Omicron variants was lower, even in the context of prior infection or infection after vaccination.

The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ – but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs.

When a team of doctors, scientists and engineers at Addenbrooke’s Hospital and the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ placed an air filtration machine in COVID-19 wards, they found that it removed almost all traces of airborne SARS-CoV-2.

The severe outbreak of COVID-19 in Delhi, India, in 2021 showed not only that the Delta variant of SARS-CoV2 is extremely transmissible but that it can infect individuals previously infected by a different variant of the coronavirus, say a team of international scientists writing in Science.

Findings suggest infection control measures against variants will need to continue in the post-vaccination era.